Medical Condition News

RSS

Scientist receives AGA-GCF Research Scholar Award for research in gastric, esophageal cancer

The American Gastroenterological Association (AGA) Research Foundation and the Gastric Cancer Foundation (GCF) are pleased to announce that the first AGA-Gastric Cancer Foundation Research Scholar Award in Gastric and Esophageal Cancer will support Mohamed El-Zaatari, PhD, from University of Michigan, as he conducts research into the role of myeloid cells in the transition from chronic inflammation to gastric pre-neoplasia.

12 Mar 2014

STS collaborates with DCRI to improve patient safety

The Society of Thoracic Surgeons continues to break new ground in patient safety and quality measurement through a new collaboration with the Duke Clinical Research Institute. DCRI will establish a link with STS clinical data and the Centers for Medicare & Medicaid Services claims data. This link will enable participants and researchers using data from the STS National Database to track long-term patient outcomes.

11 Mar 2014

MIT biologists discover how cancer cells make their escape

About 90 percent of cancer deaths are caused by tumors that have spread from their original locations. This process, known as metastasis, requires cancer cells to break loose from their neighbors and from the supportive scaffold that gives tissues their structure.

11 Mar 2014

Study finds link between elevated urinary Gb3 and heart disease

A special newly discovered biomarker, "Gb3," potentially related to the survival of heart disease patients, could change the way the country's No. 1 killer is monitored in the future, according to research published in the Feb. 4 edition of the Journal of the American Heart Association.

11 Mar 2014

Novel approach to track Montreal consumers' food choices

Poor food choices, such as overconsumption of carbonated soft drinks, are an important factor driving the global obesity epidemic and have been linked directly to diabetes and heart disease. While public health agencies are working to help people to make healthier choices, monitoring the effectiveness of these efforts has been costly and difficult. But now, using the same digital data employed by marketers to promote food products, McGill University's David Buckeridge has developed a way for health agencies to track Montreal consumers' food choices, neighborhood by neighborhood.

11 Mar 2014

CT scans predict effectiveness of chemotherapy for pancreatic cancer

Computed tomography (CT) scans routinely taken to guide the treatment of pancreatic cancer may provide an important secondary benefit. According to new research from The University of Texas MD Anderson Cancer Center, the scans also reflect how well chemotherapy will penetrate the tumor, predicting the effectiveness of treatment.

11 Mar 2014

Damage to brain cells plays role in development of epilepsy after traumatic brain injury

Traumatic brain injury is a risk factor for epilepsy, though the relationship is not understood. A new study in mice, published in Cerebral Cortex, identifies increased levels of a specific neurotransmitter as a contributing factor connecting traumatic brain injury (TBI) to post-traumatic epilepsy. The findings suggest that damage to brain cells called interneurons disrupts neurotransmitter levels and plays a role in the development of epilepsy after a traumatic brain injury.

11 Mar 2014

Monash University research offers new hope to people with heart attacks

Melbourne scientists are a step closer to creating a new drug to stop a heart attack in its tracks and reduce the damage caused, without any side effects.

11 Mar 2014

Researchers discover two new gene regions connected to bipolar disorder

First on top of the world and then in the depths of despair - this is what the extreme mood changes for people with bipolar disorder are like. Under the direction of scientists from Bonn, Mannheim and Basel, an international collaboration of researchers discovered two new gene regions that are connected to the prevalent disease. In addition, they were able to confirm three additional suspect genes.

11 Mar 2014

Innovative study uses pharmacogenomic test to treat patients with psychotic disorders

ValueOptions, Inc. a health improvement company specializing in mental and emotional well-being and recovery, and Genomind, a personalized medicine company, today announced an innovative study that uses pharmacogenomic testing to treat patients diagnosed with psychotic disorders, including schizophrenia and bipolar disorder.

11 Mar 2014

Rexahn reports initial results from Supinoxin Phase I trial in patients with solid cancer tumors

Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company announced today initial data for the Phase I dose-escalation clinical trial of SupinoxinTM (RX-5902) initiated in August 2013. This trial was designed to study safety and efficacy in patients with solid cancer tumors.

11 Mar 2014

NeuroDerm enrolls patients in second ND0612 Phase II clinical trial for treatment of Parkinson's disease

NeuroDerm, Ltd. announced today that enrollment of patients is ongoing in its second Phase II clinical trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formulation under development for continuous subcutaneous administration through a patch pump. It is designed to provide steady levodopa blood levels for the treatment of Parkinson's disease.

11 Mar 2014

Plaque in brain could guide treatment decisions for patients at risk for Alzheimer's

Brain imaging using radioactive dye can detect early evidence of Alzheimer's disease that may predict future cognitive decline among adults with mild or no cognitive impairment, according to a 36-month follow-up study led by Duke Medicine.

11 Mar 2014

Bayer and Onyx announce Phase 3 trial evaluating use of NEXAVAR for patients with HCC after local ablation

Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc., an Amgen subsidiary (Nasdaq: AMGN), today announced that a Phase 3 trial evaluating the investigational use of NEXAVAR® (sorafenib) tablets as an adjuvant treatment for patients with hepatocellular carcinoma (HCC), or liver cancer, who had no detectable disease after surgical resection or local ablation, did not meet its primary endpoint of improving recurrence-free survival.

11 Mar 2014

Study: Rise of 'selfies' have huge impact on facial plastic surgery industry

The rise of 'selfies' is having a huge impact on the facial plastic surgery industry according to a new study by the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS). The annual poll studies a select group of the organization's 2,700 members to uncover the latest trends in facial plastic surgery.

11 Mar 2014

High antibody affinity identifies type 1 diabetes

LADA (latent autoimmune diabetes in adults) is a form of type 1 diabetes in adulthood. Like the childhood form, the insulin-producing beta cells of the pancreas are destroyed by the body's own immune system.

11 Mar 2014

SCCA experts develop helpful tool to simplify colon cancer prevention, screening guidelines

Colon cancer will take more than 50,000 American lives in 2014 making it the second leading cause of cancer-related deaths, according to the American Cancer Society.

11 Mar 2014

Genetics may explain why some athletes are high functioning despite having hip abnormalities

Genetics may explain why some senior athletes are high functioning despite having one or both hip abnormalities typically associated with early onset osteoarthritis (OA): developmental dislocation of the hip (dysplasia), a loose hip joint; or femoroacetabular impingement (FAI), a condition in which the hip bones are abnormally shaped, according to new research presented today at the 2014 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).

11 Mar 2014

Researchers investigate stickiness of leukaemia cells and its link to drug resistance

Researchers in Manchester have investigated the stickiness of leukaemia cells, and whether this is linked to drug resistance.

11 Mar 2014

Parkinson's patients under risk of developing dementia can be identified quickly, say researchers

It may now be possible to identify the first-stage Parkinson's patients who will go on to develop dementia, according to a study conducted at the Institut universitaire de gériatrie de Montréal by Dr. Oury Monchi, PhD, and his postdoctoral student, Dr. Alexandru Hanganu, MD, PhD, both of whom are affiliated with Université de Montréal.

11 Mar 2014

Medical Condition News

Scientist receives AGA-GCF Research Scholar Award for research in gastric, esophageal cancer

STS collaborates with DCRI to improve patient safety

MIT biologists discover how cancer cells make their escape

Study finds link between elevated urinary Gb3 and heart disease

Novel approach to track Montreal consumers' food choices

CT scans predict effectiveness of chemotherapy for pancreatic cancer

Damage to brain cells plays role in development of epilepsy after traumatic brain injury

Monash University research offers new hope to people with heart attacks

Researchers discover two new gene regions connected to bipolar disorder

Innovative study uses pharmacogenomic test to treat patients with psychotic disorders

Rexahn reports initial results from Supinoxin Phase I trial in patients with solid cancer tumors

NeuroDerm enrolls patients in second ND0612 Phase II clinical trial for treatment of Parkinson's disease

Plaque in brain could guide treatment decisions for patients at risk for Alzheimer's

Bayer and Onyx announce Phase 3 trial evaluating use of NEXAVAR for patients with HCC after local ablation

Study: Rise of 'selfies' have huge impact on facial plastic surgery industry

High antibody affinity identifies type 1 diabetes

SCCA experts develop helpful tool to simplify colon cancer prevention, screening guidelines

Genetics may explain why some athletes are high functioning despite having hip abnormalities

Researchers investigate stickiness of leukaemia cells and its link to drug resistance

Parkinson's patients under risk of developing dementia can be identified quickly, say researchers

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News